batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Itovebi’s window of opportunity 14 October 2024 LigaChem’s L1CAM flip 10 October 2024 Pfizer doubles down in prostate cancer 10 October 2024 No stopping Astra’s pivotal TIGIT plan 10 October 2024 Keytruda could advance in head and neck 9 October 2024 J&J’s Sunrise dims 8 October 2024 Black Diamond goes all in on EGFR 8 October 2024 Opdivo approval might be good news for Astra 4 October 2024 Load More